{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:34:37Z","timestamp":1774452877762,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.mehy.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T01:51:29Z","timestamp":1536544289000},"page":"60-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia"],"prefix":"10.1016","volume":"121","author":[{"given":"Uffe","family":"Ravnskov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"de Lorgeril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-4726","authenticated-orcid":false,"given":"Malcolm","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2018.09.019_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0141076814562718","article-title":"The environment and disease: association or causation?","volume":"108","author":"Hill","year":"2015","journal-title":"J R Soc Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.1995.tb01223.x","article-title":"The prevalence of peripheral vascular disease in familial hypercholesterolaemia","volume":"238","author":"Kroon","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0015","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/0735-1097(96)00048-4","article-title":"Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high-density lipoproteins","volume":"27","author":"Hausmann","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2018.09.019_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0003319715596281","article-title":"Carotid plaques correlates in patients with familial hypercholesterolemia","volume":"67","author":"Walu\u015b-Miarka","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.mehy.2018.09.019_b0025","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.ATV.0000218507.95149.42","article-title":"Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia","volume":"26","author":"Junyent","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2018.09.019_b0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.anpedi.2008.11.017","article-title":"Evaluation of carotid intima\u2013media thickness in familial hypercholesterolemia in childhood","volume":"70","author":"Dalmau Serra","year":"2009","journal-title":"Ann Pediatr"},{"key":"10.1016\/j.mehy.2018.09.019_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0021-9150(91)90240-4","article-title":"Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia","volume":"90","author":"Postiglione","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2018.09.019_b0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committee on behalf of the Simon Broome Register Group","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2018.09.019_b0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001236","article-title":"Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992\u20132010","volume":"3","author":"Mundal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mehy.2018.09.019_b0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(99)00336-6","article-title":"Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia","volume":"149","author":"Sijbrands","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2018.09.019_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010401","article-title":"Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly. A systematic review","volume":"6","author":"Ravnskov","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.mehy.2018.09.019_b0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.322.7293.1019","article-title":"Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study","volume":"322","author":"Sijbrands","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2018.09.019_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/qjmed\/hcg150","article-title":"High cholesterol may protect against infections and atherosclerosis","volume":"96","author":"Ravnskov","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.mehy.2018.09.019_b0070","first-page":"3","article-title":"Review and hypothesis: vulnerable plaque formation from obstruction of vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies","volume":"39","author":"Ravnskov","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.mehy.2018.09.019_b0075","first-page":"24","article-title":"Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercolesterolemia","volume":"15","author":"Yamashita","year":"1987","journal-title":"Artery"},{"key":"10.1016\/j.mehy.2018.09.019_b0080","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.ATV.11.2.290","article-title":"Genetic and environmental factors affecting the incidence of coronary heart disease in heterozygous familial hypercholesterolemia","volume":"11","author":"Hill","year":"1991","journal-title":"Arterioscl Thromb"},{"key":"10.1016\/j.mehy.2018.09.019_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(93)90103-2","article-title":"Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia","volume":"101","author":"Tato","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2018.09.019_b0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.70.2.290","article-title":"Long-term effects of ileal bypass on lipoproteins in patients with familial hypercholesterolaemia","volume":"70","author":"Koivisto","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.09.019_b0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(00)04053-8","article-title":"Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial","volume":"357","author":"Smilde","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2018.09.019_b0105","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolaemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0110","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa0800742","article-title":"Simvastatin with or without ezetimibe in familial hypercholesterolaemia","volume":"358","author":"Kastelein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCULATIONAHA.113.007012","article-title":"Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolaemia: 52-week results from the open-label study of long-term evaluation against LDL-C (OSLER) randomized trial","volume":"129","author":"Koren","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2018.09.019_b0120","first-page":"2996","article-title":"ODYSSEY FH I and FH II: 78\u202fweek results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","volume":"36","author":"Kastelein","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mehy.2018.09.019_b0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10557-016-6685-y","article-title":"Efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolaemia and LDL-C of 160 mg\/dl or higher","volume":"30","author":"Ginsberg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.mehy.2018.09.019_b0135","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1253\/circj.CJ-16-0387","article-title":"Efficacy and safety of alirocumab in Japanese patients with heterozygous familial hypercholesterolaemia or at high cardiovascular risk with hypercholesterolaemia not adequately controlled with statins \u2013 ODYSSEY JAPAN randomized controlled trial","volume":"80","author":"Teramoto","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.mehy.2018.09.019_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005792-196603000-00001","article-title":"Familial hypercholesterolemia: a genetic and metabolic study","volume":"45","author":"Harlan","year":"1966","journal-title":"Medicine"},{"key":"10.1016\/j.mehy.2018.09.019_b0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/bmj.2.6085.493","article-title":"Family similarities in the age at coronary death in familial hypercholesterolaemia","volume":"2","author":"Heiberg","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2018.09.019_b0150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJM197402212900805","article-title":"Platelet function in hyperlipoproteinemia","volume":"290","author":"Carvalho","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2018.09.019_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0049-3848(82)90019-6","article-title":"The effect of human plasma on platelet function in familial hypercholesterolemia","volume":"26","author":"Aviram","year":"1982","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2018.09.019_b0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/hrt.53.3.265","article-title":"Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia","volume":"53","author":"Sugrue","year":"1985","journal-title":"Br Heart J"},{"key":"10.1016\/j.mehy.2018.09.019_b0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.ATV.6.2.203","article-title":"Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia","volume":"6","author":"DiMinno","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.mehy.2018.09.019_b0170","first-page":"113","article-title":"Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia","volume":"113","author":"Sebestjen","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.mehy.2018.09.019_b0175","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/01.ATV.0000168909.44877.a7","article-title":"Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia","volume":"25","author":"Jansen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2018.09.019_b0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0003319715579781","article-title":"Increased mean platelet volume in familial hypercholesterolemia","volume":"67","author":"Icli","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.mehy.2018.09.019_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.thromres.2006.09.002","article-title":"Assessment of mean platelet volume in coronary artery disease\u2014what does it mean?","volume":"120","author":"Boos","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.mehy.2018.09.019_b0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/039139889201500309","article-title":"Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis","volume":"15","author":"Kojima","year":"1992","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.mehy.2018.09.019_b0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jca.20256","article-title":"Coronary Hematologic and hemostatic changes induced by different columns during LDL apheresis","volume":"25","author":"Hovland","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.mehy.2018.09.019_b0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvu137","article-title":"High-density lipoprotein as a modulator of platelet and coagulation responses","volume":"103","author":"van der Stoep","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mehy.2018.09.019_b0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0038-1646543","article-title":"Hypercoagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation","volume":"61","author":"Mori","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.mehy.2018.09.019_b0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/17512433.2015.1012494","article-title":"How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease","volume":"8","author":"Diamond","year":"2015","journal-title":"Exp Rev Clin Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718304729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718304729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T11:52:46Z","timestamp":1544183566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718304729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":42,"alternative-id":["S0306987718304729"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.09.019","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}